FDA recall D-0840-2026

Product

Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC#: 60687-481-21, (Individual Dose NDC: 60687-481-11).

Reason for recall

Labeling: Label Mix-up

Distribution

US Nationwide.

Key facts

Status

Ongoing

Initiation date

2026-08-19

Report date

2026-09-09

Voluntary/Mandated

Voluntary: Firm initiated

Location

Columbus, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0840-2026